바둔진 운동이 앉아서 생활하는 젊은 및 중년 성인의 건강 개선에 미치는 효과
좌식 생활을 하는 청장년층의 건강 결과 개선에 대한 팔단금(八段錦)의 효능과 메커니즘을 평가하기 위한 다기관, 무작위 대조군 임상시험
The goal of this clinical trial is to learn if a 12-week Baduanjin exercise program can improve health in sedentary young and middle-aged adults. The main questions it aims to answer are:
- Does the Baduanjin program improve participants' cardiorespiratory fitness (measured as peak oxygen uptake)?
- Does it improve their body composition, muscle strength, balance, and flexibility?
- Does it reduce their daily sitting time?
Researchers will compare the Baduanjin training group to a health education control group to see if Baduanjin is more effective in improving these health outcomes.
Participants will:
- Be randomly assigned to one of the two groups.
- If in the Baduanjin group, attend supervised group sessions and practice at home for 12 weeks.
- Complete a series of assessments at the beginning, middle, and end of the study, including fitness tests, body measurements, and questionnaires.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Jingyi Ren, M.D., Chief Physician
- 전화번호: 18600195099
- 이메일: renjingyi@cjfh.org.cn
연구 장소
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, 중국, 100029
- 모병
- China-Japan Friendship Hospital
-
연락하다:
- Jingyi Ren, Doctor
- 전화번호: +86 17367938350
- 이메일: 1220193509@qq.com
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Adults aged 18 to 59 years
- Sedentary and physically inactive, defined as: (a) self-reported sitting time ≥ 8 hours per day, AND (b) not meeting the World Health Organization (WHO) recommended level of physical activity ( engaging in < 150 minutes of moderate-to-vigorous intensity physical activity per week, assessed by the International Physical Activity Questionnaire [IPAQ])
- In good general health as self-reported, and free from any known diseases
- Willing and able to provide written informed consent
Exclusion Criteria:
- Contraindications to cardiopulmonary exercise testing
- Currently participating in, or planning to participate within the next 3 months, in any other structured exercise or behavioral intervention program
- Pregnancy, lactation, or planning to become pregnant during the study period
- Inability to understand or comply with the study procedures
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Baduanjin Training Group
Participants in this group will receive a 12-week Baduanjin exercise program. The program consists of supervised group sessions combined with home-based practice, with a frequency of 5 sessions per week. Each session lasts 60 minutes, including warm-up, standardized Baduanjin practice, and cool-down. The Baduanjin exercises follow a standardized protocol. |
A 12-week, standardized Baduanjin exercise program. Participants will complete 5 sessions per week, each lasting 60 minutes (including warm-up, Baduanjin practice, and cool-down). The program includes both supervised group sessions and guided home practice. |
|
다른: Health Education Control Group
Participants in this group will receive general health education, which includes recommendations on physical activity types and duration (e.g., following the WHO guidelines). However, they will not be enrolled in any structured, supervised exercise program. They will be instructed to maintain their usual lifestyle throughout the study period. |
Participants will receive general health education (including recommendations on physical activity types and duration), but will not be enrolled in any structured or supervised exercise program. They will be instructed to maintain their usual lifestyle. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Change in Peak Oxygen Uptake (VO₂peak) assessed by Cardiopulmonary Exercise Testing
기간: at baseline and Week 13.
|
Measured by Cardiopulmonary Exercise Testing (CPET). |
at baseline and Week 13.
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
국제 신체 활동 설문지(IPAQ)로 평가된 좌식 행동 시간 변화
기간: 기준 시점 및 13주차에.
|
기준 시점 및 13주차에.
|
|
|
등속성 동력계로 평가한 무릎 신전 평균 파워의 변화
기간: 기준 시점, 8주차 및 13주차에.
|
기준 시점, 8주차 및 13주차에.
|
|
|
등속성 근력 측정기로 평가한 무릎 신전 피로도 지수의 변화
기간: 기저선, 8주차 및 13주차에.
|
기저선, 8주차 및 13주차에.
|
|
|
등속성 역학 측정법으로 평가한 무릎 굴곡 평균 파워 변화
기간: 기저선, 8주차 및 13주차에
|
기저선, 8주차 및 13주차에
|
|
|
등속성 역학 측정으로 평가한 무릎 굴곡 피로 지수의 변화
기간: 기준 시점, 8주차, 13주차
|
기준 시점, 8주차, 13주차
|
|
|
등속성 동력계로 평가한 어깨 굴곡 평균 파워의 변화
기간: 기준선, 8주, 그리고 13주에
|
기준선, 8주, 그리고 13주에
|
|
|
등속성 역학 검사로 평가한 어깨 굴곡 피로 지수의 변화
기간: 기준 시점, 8주차 및 13주차
|
기준 시점, 8주차 및 13주차
|
|
|
등속성 역학 측정법으로 평가한 어깨 외전 평균 파워 변화
기간: 기저 시점, 제8주 및 제13주에
|
기저 시점, 제8주 및 제13주에
|
|
|
등속성 동력계로 평가한 어깨 외전 피로 지수의 변화
기간: 기준선, 8주차 및 13주차
|
기준선, 8주차 및 13주차
|
|
|
등속성 역학 측정법으로 평가한 팔꿈치 신전 평균 파워의 변화
기간: 기저선, 8주차 및 13주차에
|
기저선, 8주차 및 13주차에
|
|
|
등속성 동력계를 통해 평가한 팔꿈치 신전 피로 지수의 변화
기간: 기준선, 8주차 및 13주차
|
기준선, 8주차 및 13주차
|
|
|
등속성 동력계로 평가한 주관절 굴곡 평균 파워 변화
기간: 기저선, 8주차 및 13주차
|
기저선, 8주차 및 13주차
|
|
|
등속성 역학 검사로 평가된 팔꿈치 굴곡 피로 지수의 변화
기간: 기준 시점, 8주차 및 13주차
|
기준 시점, 8주차 및 13주차
|
|
|
생체전기 임피던스 분석으로 평가한 근육량 변화
기간: 기준 시점 및 13주차에.
|
기준 시점 및 13주차에.
|
|
|
생체 전기 임피던스 분석법으로 평가된 체지방률 변화
기간: 기준선 및 13주차에.
|
기준선 및 13주차에.
|
|
|
생체전기 임피던스 분석으로 평가한 제지방량의 변화
기간: 기저 시점과 13주차에
|
기저 시점과 13주차에
|
|
|
3D 모션 캡처로 평가한 팔단금 운동 중 질량 중심 높이의 변화
기간: 기준 시점 및 13주차에
|
기준 시점 및 13주차에
|
|
|
표면 근전도를 통해 평가한 팔단금 운동 중 통합 근전도(iEMG)의 변화
기간: 기초선과 13주차에서
|
기초선과 13주차에서
|
|
|
표면 근전도로 평가한 팔단금 운동 중 제곱평균제곱근(RMS) 진폭 변화
기간: 기초선 및 13주차
|
기초선 및 13주차
|
|
|
처방된 팔단금 세션 완료 비율
기간: 연구 완료 시까지, 최대 13주까지.
|
연구 완료 시까지, 최대 13주까지.
|
|
|
Change in Sit-and-Reach Distance
기간: at baseline, Week 8, and Week 13.
|
Assessed by the standard sit-and-reach test. |
at baseline, Week 8, and Week 13.
|
|
Change in Active Range of Motion of the Shoulder, Hip, Knee, and Ankle joints assessed by Goniometry
기간: at baseline, Week 8, and Week 13.
|
Measured using a goniometer |
at baseline, Week 8, and Week 13.
|
|
Scores on the Exercise Benefits/Barriers Scale (EBBS)
기간: at baseline and Week 13
|
The scale consists of two subscales: the Exercise Benefits Subscale (29 items) and the Exercise Barriers Subscale (14 items). The total score ranges from 43 to 172, with a higher score indicating a more positive perception towards exercise. |
at baseline and Week 13
|
|
Change in Knee Extension Peak Torque assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13.
|
Maximum torque generated during knee extension |
at baseline, Week 8, and Week 13.
|
|
Change in Knee Extension Total Work assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13.
|
Total work performed during repeated maximal knee extension contractions. |
at baseline, Week 8, and Week 13.
|
|
Change in Knee Flexion Peak Torque assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13
|
Maximum torque generated during Knee Flexion measured at a preset angular velocity |
at baseline, Week 8, and Week 13
|
|
Change in Knee Flexion Total Work assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13
|
Total work performed during repeated maximal Knee Flexion contractions |
at baseline, Week 8, and Week 13
|
|
Change in Shoulder Flexion Peak Torque assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13
|
Maximum torque generated during Shoulder Flexion, measured at a preset angular velocity. |
at baseline, Week 8, and Week 13
|
|
Change in Shoulder Flexion Total Work assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13
|
Total work performed during repeated maximal Shoulder Flexion contractions |
at baseline, Week 8, and Week 13
|
|
Change in Shoulder Abduction Peak Torque assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13
|
Maximum torque generated during Shoulder Abduction , measured at a preset angular velocity |
at baseline, Week 8, and Week 13
|
|
Change in Shoulder Abduction Total Work assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13
|
Total work performed during repeated maximal Shoulder Abduction contractions |
at baseline, Week 8, and Week 13
|
|
Change in Elbow Extension Peak Torque assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13
|
Maximum torque generated during Elbow Extension, measured at a preset angular velocity |
at baseline, Week 8, and Week 13
|
|
Change in Elbow Extension Total Work assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13
|
Total work performed during repeated maximal Elbow Extension contractions |
at baseline, Week 8, and Week 13
|
|
Change in Elbow Flexion Peak Torque assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13
|
Maximum torque generated during Elbow Flexion, measured at a preset angular velocity |
at baseline, Week 8, and Week 13
|
|
Change in Elbow Flexion Total Work assessed by Isokinetic Dynamometry
기간: at baseline, Week 8, and Week 13
|
Total work performed during repeated maximal Elbow Flexion contractions |
at baseline, Week 8, and Week 13
|
|
Change in Rhythmic Weight Shift (RWS) Score assessed by Computerized Dynamic Posturography
기간: at baseline, Week 8, and Week 13.
|
Measured using a computerized dynamic posturography system. |
at baseline, Week 8, and Week 13.
|
|
Change in Modified Clinical Test of Sensory Interaction on Balance (mCTSIB) Score assessed by Computerized Dynamic Posturography
기간: at baseline, Week 8, and Week 13.
|
Measured using a computerized dynamic posturography system. |
at baseline, Week 8, and Week 13.
|
|
Change in Sensory Organization Test (SOT) Composite Score assessed by Computerized Dynamic Posturography
기간: at baseline, Week 8, and Week 13.
|
Measured using a computerized dynamic posturography system. |
at baseline, Week 8, and Week 13.
|
|
Change in Motor Control Test (MCT) Latency assessed by Computerized Dynamic Posturography
기간: at baseline, Week 8, and Week 13.
|
Measured using a computerized dynamic posturography system. |
at baseline, Week 8, and Week 13.
|
|
Change in Limits of Stability (LOS) Score assessed by Computerized Dynamic Posturography
기간: at baseline, Week 8, and Week 13.
|
Measured using a computerized dynamic posturography system. |
at baseline, Week 8, and Week 13.
|
|
Change in Waist-to-Hip Ratio
기간: at baseline and Week 13.
|
Ratio of waist circumference to hip circumference |
at baseline and Week 13.
|
|
Change in Center of Mass Sway Amplitude during Baduanjin Exercise assessed by 3D Motion Capture
기간: at baseline and Week 13
|
Magnitude of anteroposterior and mediolateral displacement of the body's center of mass during static postures of Baduanjin, analyzed using a markerless 3D motion capture system |
at baseline and Week 13
|
|
Change in Joint Range of Motion during Baduanjin Exercise assessed by 3D Motion Capture
기간: at baseline and Week 13
|
Angular displacement of primary joints during the performance of Baduanjin movements, analyzed using a markerless 3D motion capture system. |
at baseline and Week 13
|
|
Change in Glycemic Control Biomarkers
기간: at baseline and Week 13.
|
Fasting venous blood samples will be analyzed for indicators of glucose metabolism, such as glycated hemoglobin (HbA1c) and fasting insulin. |
at baseline and Week 13.
|
|
Change in Lipid Profile
기간: at baseline and Week 13.
|
Fasting venous blood samples will be analyzed for indicators of lipid metabolism, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). |
at baseline and Week 13.
|
|
Change in Inflammatory and Neurotrophic Biomarkers
기간: at baseline and Week 13.
|
Fasting venous blood samples will be analyzed for inflammatory markers (e.g., high-sensitivity C-reactive protein [hs-CRP], interleukin-6 [IL-6], tumor necrosis factor-alpha [TNF-α]) and brain-derived neurotrophic factor (BDNF). |
at baseline and Week 13.
|
|
Baduanjin Movement Quality Score assessed by Blinded Expert Review (100-point scale)
기간: at Week 13
|
Score assessed by blinded experts using a standardized 100-point scoring rubric. Scores range from 0 to 100, with a higher score indicating better movement quality. |
at Week 13
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- Shoufa 2024-1-4061
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .